The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy. [electronic resource]
Producer: 20060120Description: 930-9 p. digitalISSN:- 0022-3042
- Amyloid beta-Peptides -- metabolism
- Analysis of Variance
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- metabolism
- Behavior, Animal
- Benzothiazoles
- Body Weight -- drug effects
- Caspase 3
- Caspases -- metabolism
- Cell Death -- drug effects
- Cerebral Cortex -- drug effects
- Cytarabine -- metabolism
- Diagnostic Imaging -- methods
- Dopamine and cAMP-Regulated Phosphoprotein 32 -- metabolism
- Doxorubicin -- metabolism
- Dystonia -- etiology
- Electron Transport Complex III -- metabolism
- Enzyme Activation -- drug effects
- Glial Fibrillary Acidic Protein -- metabolism
- Immunohistochemistry -- methods
- Locomotion -- drug effects
- Male
- Microscopy, Electron, Transmission -- methods
- Mitochondria -- drug effects
- Neurons -- drug effects
- Phosphopyruvate Hydratase -- metabolism
- Phosphorylation
- Posture
- Psychomotor Performance -- drug effects
- Rats
- Rats, Inbred Lew
- Rotenone -- adverse effects
- Tauopathies -- chemically induced
- Thiazoles
- Time Factors
- Tyrosine -- analogs & derivatives
- Tyrosine 3-Monooxygenase -- metabolism
- Ubiquitin -- metabolism
- Uncoupling Agents -- adverse effects
- alpha-Synuclein -- metabolism
- tau Proteins -- metabolism
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.